International
The Morning Science

What science found today

‹
 

Research2 sources

Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted

MedPage Today ·

Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted

The Brief · written from 2 sources

  • A Mayo Clinic study in JAMA Neurology found that blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of mild cognitive impairment and dementia.
  • The study cohort consisted of cognitively unimpaired individuals.
  • The authors say the blood marker may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia up to 10 years ahead.

Why it matters

A blood test could eventually help identify people without symptoms who face higher future risk of cognitive decline, which matters for research on early detection of Alzheimer's disease.

Who’s affected

  • researchers and clinicians working on dementia and Alzheimer's disease
  • people concerned about their long-term cognitive risk

(MedPage Today) -- In a cohort of cognitively unimpaired individuals, blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of developing mild cognitive impairment and dementia. (JAMA Neurology) Waves of cerebrospinal...

Timeline

  1. Mayo Clinic study on blood p-tau217 and dementia risk published in JAMA Neurology

  2. MedPageToday.com - medical news for physicians

    Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted

  3. Medical Xpress - latest medical and health news stories

    Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead

Full coverage · 2 sources

How do you feel about this?

0 Comments

    Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted – The Morning Science